Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound
Shu-Guang Zheng, Hui-Xiong Xu, Lin-Na Liu, Department of Medical Ultrasound, Tenth People’s Hospital of Tongji University, Shanghai 200072, China
Author contributions: Zheng SG, Xu HX and Liu LN conducted literature research; Zheng SG wrote the paper; Liu LN prepared the figure; Xu HX edited and revised the paper.
Supported by National Natural Science Foundation of China, Nos. 81371570, 81301229 and 81301299; Key Project from Shanghai Health Bureau, No. 20114003; Shanghai Talent Development Project from Shanghai Human Resource and Social Security Bureau, No. 2012045
Correspondence to: Hui-Xiong Xu, MD, PhD, Department of Medical Ultrasound, Shanghai Tenth People’s Hospital, Tenth People’s Hospital of Tongji University, No. 301 Yanchangzhong Road, Shanghai 200072, China. xuhuixiong@hotmail.com
Telephone: +86-21-66301031 Fax: +86-21-66301031
Received: June 23, 2013
Revised: October 31, 2013
Accepted: November 15, 2013
Published online: January 28, 2014
Processing time: 229 Days and 16.2 Hours
Revised: October 31, 2013
Accepted: November 15, 2013
Published online: January 28, 2014
Processing time: 229 Days and 16.2 Hours
Core Tip
Core tip: Whether contrast enhanced ultrasound (CEUS) is comparable to contrast enhanced computed tomography/magnetic resonance imaging (CECT/CEMRI) in the management of hepatocellular carcinoma (HCC) is a controversial topic recently. Regarding to this issue, we list almost all the updated applications of CEUS in this paper and discuss the main role of CEUS in the management of HCC by comparison with CECT/CEMRI.